Eli Lilly’s experimental treatment, bamlanivimab, is a monoclonal antibody therapy, and is cleared for those 12 and older with mild-to-moderate coronavirus cases.Eli Lilly’s experimental treatment, bamlanivimab, is a monoclonal antibody therapy, and is cleared for those 12 and older with mild-to-moderate coronavirus cases.Read More
![](https://mycitycorona.com/wp-content/uploads/2020/11/5fa9e2042400003320b03f7b-KVzC9I.jpeg)